查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1922570

日本新生儿筛检市场报告：依产品类型、技术、检测类型和地区划分，2026-2034年

Japan Newborn Screening Market Report by Product, Technology, Test Type, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 118 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2025年，日本新生儿筛检市场规模达6,820万美元。展望未来，IMARC集团预测，该市场将从2026年到2034年以5.61%的复合年增长率成长，到2034年达到1.115亿美元。医疗技术的不断创新，以及为实现更准确的结果和更有效率的疾病检测而做出的努力，是推动该地区市场成长的主要动力。

新生儿筛检是指一系列检查室评估和就地检验，旨在早期发现、诊断和干预可能在出生后不会立即显现的遗传、代谢、血液和内分泌疾病。其主要目标是儘早识别可能导致严重发病率、死亡率和智能障碍的疾病，以便在症状出现前及时开始治疗。典型的新生儿筛检流程包括从婴儿足跟采集少量血液样本并进行简单的血液检测。此血液样本用于评估多种疾病，包括代谢、内分泌和血液相关疾病，例如苯酮尿症 (PKU)、镰状囊肿纤维化和镰状细胞贫血。如果初步筛检结果提示新生儿可能患有遗传性疾病，则需要进一步的检测以确诊。这有助于及时启动适当的治疗，并制定后续护理计划以维护婴儿的健康。

日本新生儿筛检市场趋势：

日本新生儿筛检市场正经历显着成长，主要驱动力来自父母对子女健康的日益关注，尤其是初为人父母者。这种关注的增加源自于婴儿先天性疾病发生率的上升。父母越来越意识到早期发现和诊断对于及时进行医疗干预和治疗至关重要，这进一步推动了市场扩张。医疗技术和基因检测的进步显着扩展了可筛检疾病的范围，进一步改善了市场前景。政府和医疗机构加速推进新生儿筛检计画也促进了市场的良性循环。持续的产品创新，例如次世代定序和串联式质谱质谱技术的整合，提高了筛检的准确性和速度，进一步推动了市场成长。消费者基因检测的广泛普及和对个人化医疗的日益重视，推动了根据个人特定基因谱量身定制的治疗方案的出现，进一步刺激了市场需求。医疗保健成本上升、数位化快速发展、互联网速度提高、线上健康社区的出现以及广泛的研发活动等因素，将在预测期内促进市场的整体成长和发展。

本报告解答的关键问题

  • 日本新生儿筛检市场至今发展状况如何？未来几年又将如何发展？
  • 新冠疫情对日本新生儿筛检市场产生了哪些影响？
  • 日本新生儿筛检市场依产品分類的组成是怎样的？
  • 日本新生儿筛检市场按技术分類的情况如何？
  • 日本新生儿筛检市场依检测类型分類的组成是怎样的？
  • 日本新生儿筛检市场价值链的不同阶段有哪些？
  • 日本新生儿筛检的主要驱动因素和挑战是什么？
  • 日本新生儿筛检市场的结构是怎么样的？主要参与者有哪些？
  • 日本新生儿筛检市场竞争有多激烈？

目录

第一章：序言

第二章：调查范围与调查方法

  • 调查目标
  • 相关利益者
  • 数据来源
  • 市场估值
  • 调查方法

第三章执行摘要

第四章 日本新生儿筛检市场—简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争资讯

第五章 日本新生儿筛检市场概览

  • 过去和当前的市场趋势（2020-2025）
  • 市场预测（2026-2034）

第六章 日本新生儿筛检市场－依产品细分

  • 装置
  • 试剂

第七章 日本新生儿筛检市场－依技术细分

  • 串联式质谱质谱法
  • 脉搏血氧计
  • 基于酵素的检测
  • DNA检测
  • 电泳
  • 其他的

第八章：日本新生儿筛检市场－依检测类型细分

  • 干血斑测试
  • CCHD
  • 听力筛检

第九章：日本新生儿筛检市场：按地区划分

  • 关东地区
  • 关西、近畿地区
  • 中部地区
  • 九州和冲绳地区
  • 东北部地区
  • 中国地区
  • 北海道地区
  • 四国地区

第十章：日本新生儿筛检市场：竞争格局

  • 概述
  • 市场结构
  • 市场公司定位
  • 关键成功策略
  • 竞争对手仪錶板
  • 企业估值象限

第十一章主要企业概况

第十二章：日本新生儿筛检市场：产业分析

  • 驱动因素、限制因素和机会
  • 波特五力分析
  • 价值链分析

第十三章附录

简介目录
Product Code: SR112026A19397

Japan newborn screening market size reached USD 68.2 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 111.5 Million by 2034, exhibiting a growth rate (CAGR) of 5.61% during 2026-2034 . Continuous innovations in medical technology for more accurate outcomes and efficiency of disease detection are primarily driving the regional market.

Access the full market insights report Request Sample

Newborn screening encompasses a series of laboratory assessments and point-of-care examinations designed for the early detection, diagnosis, and intervention of genetic, metabolic, hematological, or hormonal disorders that may not manifest immediately after birth. The primary objective is to identify diseases that have the potential to cause significant morbidity, mortality, and intellectual disability (ID) at an early stage, enabling prompt initiation of treatment before symptoms become evident. The typical newborn screening process involves the collection of a small blood sample from the baby's heel, which is subjected to a straightforward blood test. Subsequently, the blood sample undergoes testing to assess various conditions, including metabolic disorders, endocrine irregularities, and blood-related ailments such as phenylketonuria (PKU), cystic fibrosis, and sickle cell anemia. Should the initial screening results suggest a genetic disorder in the newborn, additional confirmatory testing becomes necessary to validate the diagnosis. This enables timely administration of appropriate treatment and the establishment of a follow-up care plan for the infant's well-being.

JAPAN NEWBORN SCREENING MARKET TRENDS :

The Japan newborn screening market is witnessing significant growth, primarily driven by heightened parental concerns for their children's health, especially among new parents. This concern is rooted in the increasing prevalence of congenital conditions in infants. Parents are becoming more aware of the critical role early detection and diagnosis play in facilitating timely medical intervention and treatment, further propelling the market's expansion. Advancements in medical technology and genetic testing have significantly broadened the range of disorders that can be screened for, enhancing the market's prospects. Governments and healthcare organizations are increasingly adopting newborn screening programs, adding to the market's positive trajectory. Ongoing product innovations, such as the integration of next-generation sequencing and tandem mass spectrometry, offer improved screening accuracy and speed, further bolstering market growth. The availability of direct-to-consumer genetic testing and a growing focus on personalized medicine are driving tailored treatments tailored to individuals' specific genetic profiles, further stimulating market demand. Factors such as increased healthcare expenditure, rapid digitization, higher internet speeds, the emergence of online health communities, and extensive research and development (R&D) efforts will contribute to the market's overall growth and advancement over the forecasted period.

JAPAN NEWBORN SCREENING MARKET SEGMENTATION:

Product Insights:

  • To get detailed segment analysis of this market Request Sample
  • Instruments
  • Reagents

Technology Insights:

  • Tandem Mass Spectrometry
  • Pulse Oximetry
  • Enzyme Based Assay
  • DNA Assay
  • Electrophoresis
  • Others

Test Type Insights:

  • Dry Blood Spot Test
  • CCHD
  • Hearing Screen

Regional Insights:

  • To get detailed regional analysis of this market Request Sample
  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

  • KEY QUESTIONS ANSWERED IN THIS REPORT
  • How has the Japan newborn screening market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan newborn screening market?
  • What is the breakup of the Japan newborn screening market on the basis of product?
  • What is the breakup of the Japan newborn screening market on the basis of technology?
  • What is the breakup of the Japan newborn screening market on the basis of test type?
  • What are the various stages in the value chain of the Japan newborn screening market?
  • What are the key driving factors and challenges in the Japan newborn screening?
  • What is the structure of the Japan newborn screening market and who are the key players?
  • What is the degree of competition in the Japan newborn screening market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Newborn Screening Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Newborn Screening Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Newborn Screening Market - Breakup by Product

  • 6.1 Instruments
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Forecast (2026-2034)
  • 6.2 Reagents
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)

7 Japan Newborn Screening Market - Breakup by Technology

  • 7.1 Tandem Mass Spectrometry
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Pulse Oximetry
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Enzyme Based Assay
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Forecast (2026-2034)
  • 7.4 DNA Assay
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2020-2025)
    • 7.4.3 Market Forecast (2026-2034)
  • 7.5 Electrophoresis
    • 7.5.1 Overview
    • 7.5.2 Historical and Current Market Trends (2020-2025)
    • 7.5.3 Market Forecast (2026-2034)
  • 7.6 Others
    • 7.6.1 Historical and Current Market Trends (2020-2025)
    • 7.6.2 Market Forecast (2026-2034)

8 Japan Newborn Screening Market - Breakup by Test Type

  • 8.1 Dry Blood Spot Test
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 CCHD
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)
  • 8.3 Hearing Screen
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2020-2025)
    • 8.3.3 Market Forecast (2026-2034)

9 Japan Newborn Screening Market - Breakup by Region

  • 9.1 Kanto Region
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Breakup by Product
    • 9.1.4 Market Breakup by Technology
    • 9.1.5 Market Breakup by Test Type
    • 9.1.6 Key Players
    • 9.1.7 Market Forecast (2026-2034)
  • 9.2 Kansai/Kinki Region
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Breakup by Product
    • 9.2.4 Market Breakup by Technology
    • 9.2.5 Market Breakup by Test Type
    • 9.2.6 Key Players
    • 9.2.7 Market Forecast (2026-2034)
  • 9.3 Central/ Chubu Region
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2020-2025)
    • 9.3.3 Market Breakup by Product
    • 9.3.4 Market Breakup by Technology
    • 9.3.5 Market Breakup by Test Type
    • 9.3.6 Key Players
    • 9.3.7 Market Forecast (2026-2034)
  • 9.4 Kyushu-Okinawa Region
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2020-2025)
    • 9.4.3 Market Breakup by Product
    • 9.4.4 Market Breakup by Technology
    • 9.4.5 Market Breakup by Test Type
    • 9.4.6 Key Players
    • 9.4.7 Market Forecast (2026-2034)
  • 9.5 Tohoku Region
    • 9.5.1 Overview
    • 9.5.2 Historical and Current Market Trends (2020-2025)
    • 9.5.3 Market Breakup by Product
    • 9.5.4 Market Breakup by Technology
    • 9.5.5 Market Breakup by Test Type
    • 9.5.6 Key Players
    • 9.5.7 Market Forecast (2026-2034)
  • 9.6 Chugoku Region
    • 9.6.1 Overview
    • 9.6.2 Historical and Current Market Trends (2020-2025)
    • 9.6.3 Market Breakup by Product
    • 9.6.4 Market Breakup by Technology
    • 9.6.5 Market Breakup by Test Type
    • 9.6.6 Key Players
    • 9.6.7 Market Forecast (2026-2034)
  • 9.7 Hokkaido Region
    • 9.7.1 Overview
    • 9.7.2 Historical and Current Market Trends (2020-2025)
    • 9.7.3 Market Breakup by Product
    • 9.7.4 Market Breakup by Technology
    • 9.7.5 Market Breakup by Test Type
    • 9.7.6 Key Players
    • 9.7.7 Market Forecast (2026-2034)
  • 9.8 Shikoku Region
    • 9.8.1 Overview
    • 9.8.2 Historical and Current Market Trends (2020-2025)
    • 9.8.3 Market Breakup by Product
    • 9.8.4 Market Breakup by Technology
    • 9.8.5 Market Breakup by Test Type
    • 9.8.6 Key Players
    • 9.8.7 Market Forecast (2026-2034)

10 Japan Newborn Screening Market - Competitive Landscape

  • 10.1 Overview
  • 10.2 Market Structure
  • 10.3 Market Player Positioning
  • 10.4 Top Winning Strategies
  • 10.5 Competitive Dashboard
  • 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

  • 11.1 Company A
    • 11.1.1 Business Overview
    • 11.1.2 Product Portfolio
    • 11.1.3 Business Strategies
    • 11.1.4 SWOT Analysis
    • 11.1.5 Major News and Events
  • 11.2 Company B
    • 11.2.1 Business Overview
    • 11.2.2 Product Portfolio
    • 11.2.3 Business Strategies
    • 11.2.4 SWOT Analysis
    • 11.2.5 Major News and Events
  • 11.3 Company C
    • 11.3.1 Business Overview
    • 11.3.2 Product Portfolio
    • 11.3.3 Business Strategies
    • 11.3.4 SWOT Analysis
    • 11.3.5 Major News and Events
  • 11.4 Company D
    • 11.4.1 Business Overview
    • 11.4.2 Product Portfolio
    • 11.4.3 Business Strategies
    • 11.4.4 SWOT Analysis
    • 11.4.5 Major News and Events
  • 11.5 Company E
    • 11.5.1 Business Overview
    • 11.5.2 Product Portfolio
    • 11.5.3 Business Strategies
    • 11.5.4 SWOT Analysis
    • 11.5.5 Major News and Events

12 Japan Newborn Screening Market - Industry Analysis

  • 12.1 Drivers, Restraints, and Opportunities
    • 12.1.1 Overview
    • 12.1.2 Drivers
    • 12.1.3 Restraints
    • 12.1.4 Opportunities
  • 12.2 Porters Five Forces Analysis
    • 12.2.1 Overview
    • 12.2.2 Bargaining Power of Buyers
    • 12.2.3 Bargaining Power of Suppliers
    • 12.2.4 Degree of Competition
    • 12.2.5 Threat of New Entrants
    • 12.2.6 Threat of Substitutes
  • 12.3 Value Chain Analysis

13 Appendix